| Revision as of 14:49, 30 September 2007 editRewster (talk | contribs)Extended confirmed users2,487 edits add synonym← Previous edit | Revision as of 22:31, 3 January 2008 edit undoFimbriata (talk | contribs)Autopatrolled, Extended confirmed users5,000 editsNo edit summaryNext edit → | ||
| Line 26: | Line 26: | ||
| {{Metabolic pathology}} | {{Metabolic pathology}} | ||
| ] | |||
Revision as of 22:31, 3 January 2008
Medical condition| Phosphofructokinase deficiency | |
|---|---|
| Specialty | Endocrinology  |
Phosphofructokinase deficiency, also known as Glycogen storage disease type VII or Tarui's disease, is a metabolic disorder with autosomal recessive inheritance, in which deficiency of the M subunit of the phosphofructokinase enzyme impairs the ability of cells such as erythrocytes and rhabdomyocytes to use carbohydrates (such as glucose) for energy. It may affects humans as well as other mammals (especially dogs). In humans it is the least common type of glycogen storage disease.
Presentation
The disease presents with exercise-induced muscle cramps and weakness (sometimes rhabdomyolysis), as well as with haemolytic anaemia causing dark urine a few hours later.
References
 | This article about a disease, disorder, or medical condition is a stub. You can help Misplaced Pages by expanding it. |